Skip to main content
    I

    Inspire Medical Systems Inc (INSP)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $59.07
    -2.03 (-3.32%)

    Market Cap: $1.77B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Inspire Medical Systems Inc (INSP) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Inspire Medical Systems are Si-Bone (SIBN), CONMED (CNMD) and Enovis (ENOV). Inspire Medical Systems trades at 29.1x earnings, against a median of 27.0x for the 6 of these companies with a P/E. By market cap, Inspire Medical Systems ranks 3rd of the 13 companies on this page; TransMedics Group (TMDX) is the largest at $3.17B.

    Peer Comparison

    INSP's revenue growth of -7.9% is below the peer median of 14.7%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Inspire Medical Systems (INSP)$1.77B29.1x1.9x11.4%N/A-7.9%0.00%
    Si-Bone Inc (SIBN)$1.06BN/A4.8x-6.2%-6.0%14.5%0.00%
    CONMED Corporation (CNMD)$1.51B10.4x1.1x5.4%5.2%-0.7%0.00%
    Enovis Corp (ENOV)$1.60B8.3x0.7x-22.9%-16.7%1.8%0.00%
    Integra LifeSciences Holdings (IART)$1.12B5.5x0.7x0.8%2.1%2.3%0.00%
    Iradimed Co (IRMD)$1.09B43.5x12.1x26.9%N/A14.2%0.94%
    Procept Biorobotics Corp (PRCT)$1.37BN/A3.8x-32.6%-29.2%18.0%0.00%
    iRhythm Technologies Inc (IRTC)$3.05B74.5x3.5x-4.5%-5.3%14.9%0.00%
    Tandem Diabetes Care Inc (TNDM)$1.40BN/A1.2x-4.6%-3.4%13.8%0.00%
    TransMedics Group Inc (TMDX)$3.17B70.9x4.4x19.9%7.0%41.1%0.00%
    Butterfly Network Inc (BFLY)$1.63BN/A12.4x-43.6%N/A51.7%0.00%
    Novocure Ltd (NVCR)$1.38BN/A1.8x-16.8%-21.2%15.7%0.00%
    Beta Bionics, Inc. Common Stock (BBNX)$892.71MN/A5.6x-65.3%-18.0%30.3%0.00%
    Peer median$1.39B27.0x3.7x-5.4%-5.7%14.7%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Inspire Medical Systems, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Medical Devices.

    CompanyAboutPeers
    Si-Bone Inc (SIBN)
    SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States...
    SIBN competitors
    CONMED Corporation (CNMD)
    CONMED Corporation, a medical technology company, develops, manufactures and sells surgical devices and related equipment for minimally invasive procedures...
    CNMD competitors
    Enovis Corp (ENOV)
    Enovis Corporation is a global medical technology company. The company is headquartered in Wilmington, Delaware.
    ENOV competitors
    Integra LifeSciences Holdings (IART)
    Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery...
    IART competitors
    Iradimed Co (IRMD)
    IRADIMED CORPORATION develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories...
    IRMD competitors
    Procept Biorobotics Corp (PRCT)
    PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology.
    PRCT competitors
    iRhythm Technologies Inc (IRTC)
    iRhythm Technologies, Inc., a digital healthcare company, offers ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias...
    IRTC competitors
    Tandem Diabetes Care Inc (TNDM)
    Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United...
    TNDM competitors
    TransMedics Group Inc (TMDX)
    TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ...
    TMDX competitors
    Butterfly Network Inc (BFLY)
    Butterfly Network, Inc., a digital health company, develops, manufactures, and markets ultrasound imaging solutions in the United States and internationally.
    BFLY competitors
    Novocure Ltd (NVCR)
    NovoCure Limited, an oncology company, is engaged in the development, manufacture and marketing of Optune for the treatment of a variety of solid tumors.
    NVCR competitors
    Beta Bionics, Inc. Common Stock (BBNX)
    Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development...
    BBNX competitors

    Frequently Asked Questions About INSP

    Who are Inspire Medical Systems' main competitors?

    The companies most similar to Inspire Medical Systems include Si-Bone (SIBN), CONMED (CNMD), Enovis (ENOV), Integra LifeSciences Holdings (IART) and Iradimed (IRMD), listed from the closest match.

    Who is Inspire Medical Systems' biggest competitor?

    TransMedics Group (TMDX) is the largest of the similar companies at $3.17B; Si-Bone (SIBN) is the closest match by business profile, size, sector and industry.

    How does INSP stock compare with its competitors?

    INSP's P/E is 29.1x against a peer median of 27.0x; its P/S is 1.9x against a peer median of 3.7x; its net margin is 11.4% against a peer median of -5.4%.

    Which of Inspire Medical Systems' competitors pays a higher dividend?

    Inspire Medical Systems pays no dividend. Iradimed (IRMD) has a higher forward dividend yield; Iradimed (IRMD) has the highest at 0.94%.

    Is Inspire Medical Systems bigger than its competitors?

    No. Inspire Medical Systems is 3rd by market cap among the 13 companies on this page; the largest is TransMedics Group (TMDX) at $3.17B.